23andMe has been testing the waters for a buyer for Lemonaid Health, the virtual-care business it bought in 2021 for $400 million in cash and stock, people with knowledge of the efforts told BI.

The struggling health company bought virtual care startup Lemonaid in 2021 for $400 million. 23andMe's stock has plummeted after a 2023 data breach exposed millions of customer accounts.

Investing.com -- Genetic testing firm 23andMe is reportedly considering the sale of its telehealth division, Lemonaid Health, according to Business Insider. The company, which has faced financial ...

The struggling health company bought virtual care startup Lemonaid in 2021 for $400 million. 23andMe's stock has plummeted after a 2023 data breach exposed millions of customer accounts. Struggling ...

Priv Health offers services tailored to men’s health needs, including sexual health (erectile dysfunction, premature ejaculation, low testosterone), hair care (hair loss and thinning), mental ...

Even before the dust on the sexual assault on a young student inside the campus of Anna University in the city had settled another incident was reported in the city on Tuesday. A research scholar ...